Redwood City medical device maker Pulmonx sets targets for $123M IPO

Pulmonx Corp., which makes minimally invasive medical devices for emphysema, set price targets Thursday for an IPO in which it hopes to raise up to $123 million. This is the Redwood City company's second attempt this year at going public after shelving an earlier plan to raise up to $86 million. It withdrew that filing after raising $66 million privately in May. The 202-employee company expects to list on the Nasdaq exchange as “LUNG.” It is offering 6.7 million shares for between $14 and $16…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news